ViiV Healthcare's EMBRACE study shows VH109 with CAB LA effectively suppresses HIV. The company also reports promising early ...
NEW YORK CITY, NY / ACCESS Newswire / March 11, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, ...
Immune responses against serogroups A, C, W, and Y were noninferior between the MenABCWY and MenACWY-CRM vaccines in young adults and adolescents.
One of the most highly anticipated FDA decisions this month is for Alnylam Pharmaceuticals, which is seeking to expand the ...
CBO Abbas Kazimi will replace longtime CEO Jeb Keiper as part of a planned leadership transition at the unorthodox drug ...
We recently compiled a list of the 10 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where GSK ...
Multinational pharmaceutical company GSK’s commitment to invest up to $800 million in its facility near Marietta may have ...
An international collaboration of researchers, sponsored by GSK and working on behalf of the ANCHOR-1 and ANCHOR-2 trial ...
Clinical Trials Arena on MSN11d
GSK reports positive outcomes from two Phase III trials of treatment for CRSwNPSecondary endpoint analyses from the trials showed 'significant improvements' in patients treated with the antibody.
Michelle says it was “deeply disappointing” that one of her first meetings after being elected in July involved learning that the GSK site was going to close. "Over the years, all of my family have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback